• 3811 Citations
  • 30 Scopus h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Esteban D Braggio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Waldenstrom Macroglobulinemia Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Genome Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 3811 Citations
  • 30 Scopus h-Index
  • 85 Article
  • 5 Chapter
  • 4 Letter
  • 1 Review article

Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report

Ruiz-Heredia, Y., Sanchez-Vega, B., Barrio, S., Linares, M., Rapado, I., Braggio, E. D., Stewart, K., Folgueira, M. D., Ramos, A., Collado, L., Ruiz, J., Toldos, O., Hernandez-Lain, A. & Martinez-Lopez, J., Jun 1 2019, In : Journal of Oncology Pharmacy Practice. 25, 4, p. 998-1002 5 p.

Research output: Contribution to journalArticle

Progressive Multifocal Leukoencephalopathy
Multiple Myeloma
Central Nervous System
Dexamethasone
JC Virus
4 Citations (Scopus)

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Shanafelt, T. D., Wang, X. V., Kay, N. E., Hanson, C. A., O'Brien, S., Barrientos, J., Jelinek, D. F., Braggio, E. D., Leis, J. F., Zhang, C. C., Coutre, S. E., Barr, P. M., Cashen, A. F., Mato, A. R., Singh, A. K., Mullane, M. P., Little, R. F., Erba, H., Stone, R. M., Litzow, M. R. & 1 others, Tallman, M., Aug 1 2019, In : The New England journal of medicine. 381, 5, p. 432-443 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Disease-Free Survival
Confidence Intervals
Immunoglobulin Heavy Chains
Cyclophosphamide
3 Citations (Scopus)

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

Zhu, Y. X., Shi, C. X., Bruins, L. A., Wang, X., Riggs, D. L., Porter, B., Ahmann, J. M., de Campos, C. B., Braggio, E. D., Bergsagel, P. L. & Stewart, A. K., Feb 1 2019, In : Blood cancer journal. 9, 2, 19.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Cell Line
Down-Regulation
lenalidomide
Sequence Deletion

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Therapeutics
Databases
1 Citation (Scopus)

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Vendramini, E., Bomben, R., Pozzo, F., Benedetti, D., Bittolo, T., Rossi, F. M., Dal Bo, M., Rabe, K. G., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Braggio, E. D., Parikh, S. A., Kay, N. E., Shanafelt, T. D., Del Poeta, G., Gattei, V. & Zucchetto, A., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

Open Access
Trisomy
B-Cell Chronic Lymphocytic Leukemia
Mutation